Table 1.
HSP vaccine | Target carcinoma | Clinical trial | Reference |
---|---|---|---|
Vitepsin-Gp96-based vaccine | Several-liver, ovarian, glioma, melanoma, etc. | Phases II and III, approved in some places. | [67] |
HSP.PC 96-Gp96-based vaccine | Renal carcinoma | Phases II and III | [68] |
HSP. 70PC-HSP70-based vaccine | Breast cancer | Phase I | [69] |
HPV16oE7-HSP70-based vaccine | Cervical cancer | [50] |